Other grades of this product :
| storage temp. | -20°C | | form | Solid |
| Uses | CTAP acts as a selective μ-opioid receptor antagonist with a multitude of applications including the regulation of aggressive behavior in mammals. Activation of μ-opioid receptors in the central nucleus of the amygdala, is responsible for mechanisms related to the control of sodium appetite and regulation of sodium intake. | | Uses | CTAP has been used as a μ-opioid receptor (MOR) antagonist: - to study the anti-hyperalgesic effect of dipeptidyl peptidase 4 (DPP4) inhibitor isoleucine-proline-isoleucine (IPI) and vildagliptin in carrageenan-induced inflammation
- to study the role of MOR in glutamate and gamma-aminobutyric acid (GABA) efflux during predator stress in rats
- to determine the endogenous opioid peptide involved in blocking pain induced by activated gastrin-releasing peptide (Grp+) neurons
| | Biochem/physiol Actions | CTAP is a peptide antagonist produced from somatostatin analogs. |
| CTAP Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye